BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37742859)

  • 1. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
    Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
    Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-chain per- and polyfluoralkyl substances (PFAS) effects on oxidative stress biomarkers in human liver, kidney, muscle, and microglia cell lines.
    Solan ME; Koperski CP; Senthilkumar S; Lavado R
    Environ Res; 2023 Apr; 223():115424. PubMed ID: 36740157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An
    Solan ME; Lavado R
    Curr Res Toxicol; 2023; 5():100116. PubMed ID: 37575337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.
    Marques E; Pfohl M; Wei W; Tarantola G; Ford L; Amaeze O; Alesio J; Ryu S; Jia X; Zhu H; Bothun GD; Slitt A
    Toxicol Appl Pharmacol; 2022 May; 442():115991. PubMed ID: 35337807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental transport of per- and polyfluoroalkyl substances (PFAS): Mechanism exploration via BeWo cell monolayer model.
    Chen H; Wei S; Li J; Zhong Z; Chen D
    J Hazard Mater; 2024 Mar; 466():133205. PubMed ID: 38278074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenic activity of alternative per- and polyfluoroalkyl substances (PFAS): Mechanistic in vitro studies.
    Pierozan P; Cattani D; Karlsson O
    Sci Total Environ; 2022 Feb; 808():151945. PubMed ID: 34843762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Per- and polyfluoroalkyl substances (PFAS) in United States tapwater: Comparison of underserved private-well and public-supply exposures and associated health implications.
    Smalling KL; Romanok KM; Bradley PM; Morriss MC; Gray JL; Kanagy LK; Gordon SE; Williams BM; Breitmeyer SE; Jones DK; DeCicco LA; Eagles-Smith CA; Wagner T
    Environ Int; 2023 Aug; 178():108033. PubMed ID: 37356308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects and bioconcentration of per- and polyfluoroalkyl substances (PFASs) in zebrafish (Danio rerio) embryos.
    Menger F; Pohl J; Ahrens L; Carlsson G; Örn S
    Chemosphere; 2020 Apr; 245():125573. PubMed ID: 31877453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of per- and polyfluoroalkyl substances in Biscayne Bay surface waters and tap waters from South Florida.
    Li X; Fatowe M; Cui D; Quinete N
    Sci Total Environ; 2022 Feb; 806(Pt 1):150393. PubMed ID: 34562756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
    Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive target analysis and TOP assay of per- and polyfluoroalkyl substances (PFAS) in wild boar livers indicate contamination hot-spots in the environment.
    Rupp J; Guckert M; Berger U; Drost W; Mader A; Nödler K; Nürenberg G; Schulze J; Söhlmann R; Reemtsma T
    Sci Total Environ; 2023 May; 871():162028. PubMed ID: 36740073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.
    Modaresi SMS; Wei W; Emily M; DaSilva NA; Slitt AL
    Toxicology; 2022 Jan; 465():153044. PubMed ID: 34800597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency Ranking of Per- and Polyfluoroalkyl Substances Using High-Throughput Transcriptomic Analysis of Human Liver Spheroids.
    Reardon AJF; Rowan-Carroll A; Ferguson SS; Leingartner K; Gagne R; Kuo B; Williams A; Lorusso L; Bourdon-Lacombe JA; Carrier R; Moffat I; Yauk CL; Atlas E
    Toxicol Sci; 2021 Oct; 184(1):154-169. PubMed ID: 34453843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per- and Polyfluoroalkyl Substances in Ducks and the Relationship with Concentrations in Water, Sediment, and Soil.
    Sharp S; Sardiña P; Metzeling L; McKenzie R; Leahy P; Menkhorst P; Hinwood A
    Environ Toxicol Chem; 2021 Mar; 40(3):846-858. PubMed ID: 32672850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublethal Exposure of Per- and Polyfluoroalkyl Substances of Varying Chain Length and Polar Functionality Results in Distinct Metabolic Responses in Daphnia magna.
    Labine LM; Oliveira Pereira EA; Kleywegt S; Jobst KJ; Simpson AJ; Simpson MJ
    Environ Toxicol Chem; 2023 Jan; 42(1):242-256. PubMed ID: 36345965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS).
    Solan ME; Lavado R
    J Appl Toxicol; 2022 Aug; 42(8):1298-1309. PubMed ID: 34873727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Per- and polyfluoroalkyl substances activate UPR pathway, induce steatosis and fibrosis in liver cells.
    Qi Q; Niture S; Gadi S; Arthur E; Moore J; Levine KE; Kumar D
    Environ Toxicol; 2023 Jan; 38(1):225-242. PubMed ID: 36251517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study on extractable organofluorine and per- and polyfluoroalkyl substances (PFAS) in water from drinking water treatment plants around Taihu Lake, China: what is missed by target PFAS analysis?
    Jiao E; Zhu Z; Yin D; Qiu Y; Kärrman A; Yeung LWY
    Environ Sci Process Impacts; 2022 Jul; 24(7):1060-1070. PubMed ID: 35687097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal relative potency factors based on immunotoxicity for the risk assessment of mixtures of per- and polyfluoroalkyl substances (PFAS) in human biomonitoring.
    Bil W; Ehrlich V; Chen G; Vandebriel R; Zeilmaker M; Luijten M; Uhl M; Marx-Stoelting P; Halldorsson TI; Bokkers B
    Environ Int; 2023 Jan; 171():107727. PubMed ID: 36628859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
    Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
    Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.